These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 7241512

  • 21. Ligand binding studies, preliminary structure-activity relationship and detailed mechanistic characterization of 1-phenyl-6,6-dimethyl-1,3,5-triazine-2,4-diamine derivatives as inhibitors of Escherichia coli dihydrofolate reductase.
    Srinivasan B, Tonddast-Navaei S, Skolnick J.
    Eur J Med Chem; 2015 Oct 20; 103():600-14. PubMed ID: 26414808
    [Abstract] [Full Text] [Related]

  • 22. A general QSAR for dihydrofolate reductase inhibition by 2,4-diaminotriazines based upon molecular shape analysis.
    Hopfinger AJ.
    Arch Biochem Biophys; 1981 Jan 20; 206(1):153-63. PubMed ID: 7212714
    [No Abstract] [Full Text] [Related]

  • 23. Quantitative structure-activity relationships by neural networks and inductive logic programming. II. The inhibition of dihydrofolate reductase by triazines.
    Hirst JD, King RD, Sternberg MJ.
    J Comput Aided Mol Des; 1994 Aug 20; 8(4):421-32. PubMed ID: 7815093
    [Abstract] [Full Text] [Related]

  • 24. Pharmacokinetics of Aryldihydro-s-triazines with antifolate activity II: Blood levels and their relevance to antineoplastic activity in rats.
    Upton RA, Ashley JJ, Ryan AJ.
    J Pharm Sci; 1978 Mar 20; 67(3):310-4. PubMed ID: 641713
    [Abstract] [Full Text] [Related]

  • 25. Irreversible enzyme inhibitors. 173. Cure of Walker 256 ascites by reversible and irreversible inhibitors of dihydrofolic reductase derived from 1-(substituted-phenyl)-4,6-diamino-1,2-dihydro-2,2-dimethyl-s-triazine.
    Baker BR, Vermeulen NM, Ashton WT, Ryan AJ.
    J Med Chem; 1970 Nov 20; 13(6):1130-40. PubMed ID: 5479852
    [No Abstract] [Full Text] [Related]

  • 26. Triazines and related products. IX. Potential irreversible dihydrofolate reductase inhibitors: 2,4-diamino-S-triazines with a masked covalent labelling group.
    Mackenzie SM, Stevens MF.
    J Chem Soc Perkin 1; 1972 Nov 20; 3():295-8. PubMed ID: 5065592
    [No Abstract] [Full Text] [Related]

  • 27. Irreversible enzyme inhibitors. CLXXIV. Metabolism of 4-(p-(4,6-diamino-1,2-dihydro-2,2-dimethyl-s-triazin-1-yl)hydrocinnamido)-o-toluenesulfonyl fluoride (NSC-113423), an active-site-directed irreversible inhibitor of dihydrofolic reductase.
    Ryan AJ, Vermeulen NM, Baker BR.
    J Med Chem; 1970 Nov 20; 13(6):1140-2. PubMed ID: 5479853
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Quantitative structure-activity relationship of triazine-antifolate inhibition of Leishmania dihydrofolate reductase and cell growth.
    Booth RG, Selassie CD, Hansch C, Santi DV.
    J Med Chem; 1987 Jul 20; 30(7):1218-24. PubMed ID: 3599028
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. A comparison of the inhibitory action of 5-(substituted-benzyl)-2,4-diaminopyrimidines on dihydrofolate reductase from chicken liver with that from bovine liver.
    Li R, Hansch C, Kaufman BT.
    J Med Chem; 1982 Apr 20; 25(4):435-40. PubMed ID: 7069722
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Irreversible enzyme inhibitors. CLIX. Effect of substitution on transport and isozyme specificity of p-(4,6-diamino-1,2-dihydro-2,2-dimethyl-s-triazin-1-yl)-o-chlorophenoxyacetamido-benzenesulfonyl fluoride, an active-site-directed irreversible inhibitor of dihydrofolic reductase.
    Baker BR, Ashton WT.
    J Med Chem; 1969 Sep 20; 12(5):894-7. PubMed ID: 5812207
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.